Access cutting-edge iga nephropathy treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Miami location
Preparing your pre-screening questions…
Access iga nephropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related iga nephropathy treatment provided free
Check if you qualify for this iga nephropathy clinical trial in Miami, FL
No-Cost Study Care
Local to Miami
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of the study is to evaluate safety, tolerability, and preliminary effectiveness following administration of PS-002 in adults with primary Immunoglobulin A (IgA) nephropathy. This will be a first-in-human study and will include participants at high risk of disease progression despite receiving current standard-of-care treatment. Participants will be monitored for up to one year after receiving PS-002 and invited to take part in a long-term follow-up study (total follow-up: 5 years).
Sponsor: Purespring Therapeutics Limited
Yes, this clinical trial (NCT07182227) has an active research site in Miami, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for iga nephropathy treatment options in Miami, FL, this clinical trial (NCT07182227) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iga nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all iga nephropathy clinical trials near you to find additional studies recruiting in your area.
See all iga nephropathy clinical trials recruiting in Miami — not just this study.
Browse IgA Nephropathy Trials in Miami →